Alzheimer’s drug shows promise in early results of study...

[DGUtley]

Alzheimer’s drug shows promise in early results of study...

1000.jpeg

Shares of Biogen and other drugmakers researching Alzheimer’s disease soared Wednesday after Japan’s Eisai Co. said its potential treatment appeared to slow the fatal disease in a late-stage study. The drugmaker said early results showed that its treatment, lecanemab, reduced patient clinical decline by 27% when compared to a placebo or fake drug after 18 months of the infused treatment.

Eisai announced results late Tuesday from a global study of nearly 1,800 people with early-stage Alzheimer’s. Patients were monitored using a scale that measures mental decline and their ability to do daily activities like getting dressed or feeding oneself. Eisai Co. Ltd. said it would discuss full results from the research at a conference in late November. It also plans to publish findings in a peer-reviewed medical journal.

A statement from the Alzheimer’s Association called the findings the most encouraging to date for potential treatments of the underlying disease causes. Some 6 million people in the U.S. and many more worldwide have Alzheimer’s, which gradually attacks areas of the brain needed for memory, reasoning, communication and basic daily tasks.

Applause2.gif


Moneydive.gif

Money.gif


Applause.gif

[jigglepete]

This is great, if they can remember where they put them...